Medical Licensing (MD/DO) · Independent exam preparation
Dermatopathology Subspecialty Certification: Diagnostic Reasoning Guide Study Guide
Practise pattern recognition, specimen selection, ancillary-test interpretation and consequential tumor reporting.
By CertMedbry · Updated 15 October 2026
This selective guide develops 60 diagnostic decisions across the dermatopathology domains. The official blueprint marked Updated for 2026 and the final 12/2025 content specifications define the full examination scope, including additional clinical, nail-unit and mucosal material. The specifications also caution that their topic list is not exhaustive. Study these explanations alongside supervised slide review, practical-image interpretation and whole-slide microscopy. For each case, identify the dominant compartment, describe the defining findings, compare realistic alternatives and determine which additional observation would change the diagnosis.
Try 20 free practice questionsWhat is the exam format?
Check the question types, timing and outline before planning your revision.
Which certification does this guide address?
It addresses the Dermatopathology Subspecialty Certification Exam, a joint ABD–ABPath certification function. ABPath is the Sponsoring Board and ABD the Administrative Board. Dermatopathology fellowship training serves physicians from dermatology and eligible pathology backgrounds. This examination is distinct from the general dermatology CORE dermatopathology module.
ABD — Dermatopathology · ABD — Dermatopathology Subspecialty Certification Exam FAQ
How many questions are there?
The official description lists 160 written/practical questions and 110 virtual microscopy questions, totaling 270. It does not identify a scored-versus-pretest breakdown, so these totals should not be described as verified scored-item counts.
How long is the examination?
Written/practical testing allows 3 hours 13 minutes; virtual microscopy allows 4 hours 9 minutes. Combined testing time is 7 hours 22 minutes, or 442 minutes. The detailed 2026 daily schedule allocates 592 minutes overall, or 9 hours 52 minutes: 442 minutes of testing, 120 minutes of optional breaks, 20 minutes for the honor code/tutorial and 10 minutes for the survey. Candidates can shorten the day by shortening or declining optional breaks. ABD's general page describes an eight-hour examination, which is inconsistent with this detailed 2026 schedule.
ABPath — Dermatopathology Exam Description · 2026_DP-Exam-Schedule-Remote_1-day_FINAL.pdf · ABD — Dermatopathology
How is the examination delivered?
The examination is computer based and administered at Pearson Test Centers. Microscopy uses virtual slides; there are no glass slides. The issuer descriptions do not characterize the examination as computer adaptive.
ABPath — Dermatopathology Exam Description · ABD — Dermatopathology
What question styles and images should candidates expect?
Official questions use a multiple-choice, one-best-answer format. Practical material includes gross lesions and immunofluorescent, histochemical, microbiologic and cytologic preparations. Assessed skills include diagnosis, ancillary testing, clinical and laboratory knowledge, management, quality and consultation. The questions here are independent educational exercises and do not reproduce the image examination or predict a passing result.
Which documents define the full scope?
The blueprint marked Updated for 2026 and the final content specifications dated 12/2025 define the full scope. No separate effective day is stated. The specifications include fellow-level knowledge with foundational and advanced-resident material and caution that their topic list is not exhaustive. These 60 concepts are selective foundations rather than a complete representation of those documents.
ABPath — Subspecialty Exam Blueprints and Daily Schedules · Dermatopathology Exam Blueprint — Updated for 2026 · ABPath — Content Specifications for Examinations · Dermatopathology Content Specifications — 12/2025
How do the two section blueprints differ?
Approximate written/practical versus virtual microscopy percentages are: Inflammatory Reaction Patterns 20/24; The Epidermis 5/4; The Dermis 7/5; Normal Skin 3/2; Artifacts 3/1; Diseases of Cutaneous Appendages 7/5; Cysts, Sinuses and Pits 3/2; Panniculitis 3/5; Metabolic and Storage Diseases 3/5; Infections and Infestations 14/16; Tumors 25/31; Laboratory and Special Procedures 6/0; Management & Informatics-General 1/0. Each column independently totals 100%. The columns describe separate section distributions.
Which eligibility distinctions matter for ABD candidates?
ABD describes accredited fellowship training and a full, unrestricted medical or osteopathic license in the United States or Canada. Its eligibility FAQ describes five years after fellowship while maintaining ABD primary certification or eligibility for it. The broader requirements page and FAQ describe primary-certification status differently; applicants should resolve their individual status with ABD. These are ABD pathway statements rather than universal ABPath application requirements.
ABD — Dermatopathology · ABD — Dermatopathology Subspecialty Certification Exam FAQ
The guide emphasizes diagnostic mechanisms, discriminating morphology and the boundaries of ancillary tests. A persuasive interpretation connects the specimen findings to a clinical question and states consequential sampling limitations.
Outline used: ABPath Dermatopathology Exam Blueprint, marked 'Updated for 2026', and final Dermatopathology Content Specifications dated 12/2025. Both were opened live during this review. No separate effective day is stated. The assigned workbook label maps to the joint ABD–ABPath dermatopathology subspecialty certification examination; its canonical slug is preserved.
60 key concepts: understand, apply and avoid the traps
Work through the questions by exam domain. Explain the answer in your own words, try the example, then check the common pitfall.
Inflammatory Reaction PatternsWritten/practical 20%; virtual microscopy 24%
1.Which microscopic combination most strongly supports psoriasis?
Psoriasis is supported by a coordinated psoriasiform pattern: relatively regular rete elongation, suprapapillary thinning, dilated papillary vessels, parakeratosis and neutrophils in the cornified layer. Reduced granular layer beneath parakeratosis adds support. No single feature is obligatory, and clinically confirmed lesions can lack textbook architecture. Evaluate whether the findings collectively fit psoriasis better than another psoriasiform dermatitis, considering lesion site, age and treatment.
Apply it
An extensor plaque shows regular rete elongation, thin suprapapillary plates and neutrophilic collections in parakeratosis. Integrate architecture and cornification rather than diagnosing from epidermal thickening alone.
Common pitfall: Acanthosis is nonspecific. Its significance depends on the distribution of spongiosis, inflammation, vascular changes and abnormal keratinization throughout the specimen.
2.How does spongiotic dermatitis differ from a predominantly psoriasiform reaction?
Spongiosis is intercellular epidermal edema that stretches intercellular bridges and can produce vesicles. Prominent spongiosis with lymphocytic exocytosis supports an eczematous reaction. Regular rete elongation, suprapapillary thinning and neutrophilic parakeratosis favor psoriasis. Chronic eczema can become psoriasiform, and psoriasis can contain some spongiosis, so identify the dominant coordinated pattern. Treatment and lesion duration can attenuate characteristic findings and increase overlap between these reaction patterns.
Apply it
An itchy plaque has irregular epidermal hyperplasia, conspicuous intercellular edema and focal vesiculation. Describe a spongiotic pattern and correlate exposures, distribution and treatment.
Common pitfall: Eosinophils may support allergic or drug-related possibilities, but they do not identify a specific exposure or establish the cause of an eczematous eruption.
3.How does the level of a blister organize the diagnostic workup?
The cleavage level is an initial anatomic discriminator. Intraepidermal separation with acantholysis directs attention toward disorders of keratinocyte adhesion. Subepidermal separation directs attention toward basement-membrane-zone disease and other causes of dermoepidermal separation. Routine histology establishes architecture and inflammatory composition; direct immunofluorescence identifies deposited immunoreactants. Combining these observations is more informative than assigning a disease from cleavage level alone, particularly when the lesion is old or eroded.
Apply it
A fresh vesicle shows a subepidermal split with eosinophils. Establish the plane first, then obtain appropriately handled perilesional tissue for direct immunofluorescence.
Common pitfall: A subepidermal split is a shared reaction pattern. Erosion and secondary tissue damage can obscure the original plane and remove diagnostically useful epithelium.
4.How do desmoglein antibodies connect pemphigus fluorescence, cleavage level and mucosal disease?
Pemphigus classically shows netlike intercellular epidermal IgG, often with C3. Desmogleins are desmosomal cadherins supporting adhesion between keratinocytes; pathogenic antibodies impair this adhesion and produce acantholysis. Desmoglein 3 antibodies usually accompany mucosal-dominant pemphigus vulgaris, while combined desmoglein 3 and desmoglein 1 antibodies usually accompany mucocutaneous vulgaris. Vulgaris typically cleaves suprabasally. Desmoglein 1 antibodies characterize pemphigus foliaceus, with superficial acantholysis and usual mucosal sparing. Desmoglein 3 predominates in lower epidermis and is abundant in mucosa; desmoglein 1 is strongest superficially in skin and relatively limited in mucosa. Overlapping expression permits partial compensation, helping explain these distributions. These associations have exceptions, so correlate serology, histology and phenotype. Primary support: [antigen localization](https://pubmed.ncbi.nlm.nih.gov/8601740/), [experimental compensation](https://pubmed.ncbi.nlm.nih.gov/10021453/) and [antibody–phenotype relationships](https://pubmed.ncbi.nlm.nih.gov/11298536/).
Apply it
Mucosal erosions, suprabasal acantholysis and intercellular IgG support vulgaris. Desmoglein 3 reactivity without desmoglein 1 fits the usual mucosal-dominant profile; accompanying skin disease warrants assessment of both antibodies.
Common pitfall: Intercellular staining identifies the pemphigus family but does not itself determine the antigen profile. Antibody results and the compensation model do not predict every patient's distribution perfectly.
5.What does linear basement-membrane staining establish in a blistering eruption?
Linear immunoreactants along the basement membrane support an autoimmune subepidermal blistering process when clinical and histologic findings agree. Bullous pemphigoid commonly shows linear IgG and C3, but other disorders share this distribution. Immunoglobulin class, salt-split localization and antigen-specific studies refine classification. Distinguish the observed deposition pattern from an established antigen-specific diagnosis, especially when scarring, prominent mucosal involvement or unusual clinical features suggest an alternative basement-membrane disorder.
Apply it
Tense bullae, an eosinophil-rich subepidermal blister and linear IgG/C3 favor bullous pemphigoid. Atypical clinical features justify further localization and antigen-specific assessment.
Common pitfall: Linear IgG does not uniquely identify bullous pemphigoid. Several basement-membrane disorders require additional localization or antigen evidence despite similar initial fluorescence.
Utility of immunofluorescence in dermatology · Epidermolysis Bullosa Acquisita: A Report of Four Cases
6.How does salt-split localization distinguish pemphigoid from epidermolysis bullosa acquisita?
Salt splitting creates an artificial separation through the lamina lucida, allowing antibody binding to be assigned to the epidermal roof or dermal floor. Bullous pemphigoid usually binds the roof. Epidermolysis bullosa acquisita, associated with type VII collagen autoimmunity, usually binds the floor. Floor binding narrows the differential but is shared by other disorders. Clinical phenotype and antigen-specific evidence therefore remain necessary when several dermal-binding diseases are plausible.
Apply it
Trauma-related blisters and milia accompany linear IgG with floor binding. Investigate type VII collagen reactivity rather than assigning ordinary bullous pemphigoid from linear staining alone.
Common pitfall: Salt-split localization identifies the side of binding, not the antigen itself. A dermal-floor result supports further discrimination rather than one exclusive diagnosis.
Epidermolysis Bullosa Acquisita: A Report of Four Cases · Utility of immunofluorescence in dermatology
7.Which fluorescence distribution supports dermatitis herpetiformis?
Granular IgA in dermal papillary tips, sometimes extending along the dermoepidermal junction, supports dermatitis herpetiformis in the appropriate setting. The granular distribution differs from the continuous linear IgA deposition of linear IgA bullous disease. Histology may show papillary neutrophils and subepidermal separation, but those findings are less specific. Perilesional sampling preserves useful immune deposits better than a completely eroded lesion and helps connect the inflammatory pattern to its immune classification.
Apply it
Pruritic grouped extensor vesicles accompany papillary neutrophils. Granular papillary IgA on perilesional direct immunofluorescence supplies the discriminating evidence for dermatitis herpetiformis.
Common pitfall: Neutrophils in a subepidermal blister do not uniquely identify dermatitis herpetiformis. Distinguish granular papillary IgA from continuous linear junctional IgA before classification.
8.How do interface patterns guide comparison of lichen planus and cutaneous lupus?
Interface dermatitis reflects basal keratinocyte injury, including vacuolization and apoptotic keratinocytes. A dense junctional lymphocytic band with wedge-shaped hypergranulosis and saw-tooth acanthosis favors lichen planus. Vacuolar injury with perivascular and periadnexal inflammation, basement-membrane thickening and dermal mucin favors cutaneous lupus, although overlap occurs. Junctional immune deposits can provide support, but their interpretation depends on biopsy site, sun exposure and lesional status. A lupus-band result alone does not establish systemic lupus.
Apply it
Compare a violaceous papule with junctional inflammation and hypergranulosis against a photosensitive plaque with adnexal inflammation and mucin. Use accompanying architecture to refine the shared interface pattern.
Common pitfall: Basal vacuolization and colloid bodies occur in several conditions. Neither interface injury nor junctional fluorescence independently supplies a complete clinical classification.
9.How is inflammatory vasculitis distinguished from thrombotic vasculopathy?
Vasculitis requires inflammatory injury centered on vessel walls, potentially including fibrinoid change, wall disruption and leukocytoclasia. Thrombotic vasculopathy is dominated by luminal thrombosis and ischemic injury with comparatively little primary wall inflammation. Both can produce purpura or necrosis, and secondary inflammation can complicate interpretation. Determine whether destructive mural inflammation or occlusion is the organizing process. That distinction changes the clinicopathologic differential and the subsequent investigation of the vascular injury.
Apply it
Retiform purpura shows numerous occluded vessels with minimal mural inflammation. Describe a thrombotic vasculopathy pattern and correlate its distribution and possible underlying causes.
Common pitfall: Clinical purpura and extravasated erythrocytes do not prove vasculitis. Neither demonstrates the destructive vessel-wall inflammation required to establish that morphologic pattern.
Cutaneous vasculitis and vasculopathy in the era of COVID-19 pandemic
10.Which findings establish a leukocytoclastic vasculitis pattern?
Leukocytoclastic vasculitis is a small-vessel injury pattern characterized by neutrophils involving vessel walls, fragmented neutrophilic nuclei, fibrinoid vascular damage and erythrocyte extravasation. The term describes morphology rather than a single cause. Drugs, infections, systemic inflammatory disease and immune-complex disorders can produce similar appearances. Establish actual wall injury before classifying the pattern, then combine clinical history and appropriately selected immunofluorescence findings to investigate the setting and possible systemic significance.
Apply it
Palpable purpura shows neutrophilic wall infiltration, nuclear dust and fibrinoid damage. Report the pattern and correlate medications, infection history, systemic symptoms and immune deposits.
Common pitfall: Perivascular neutrophils alone are insufficient. Avoid turning a morphologic diagnosis into an unsupported claim about a particular drug, infection or systemic disorder.
Cutaneous vasculitis and vasculopathy in the era of COVID-19 pandemic
11.What does vascular IgA deposition add to a purpura biopsy?
Predominant vascular IgA supports IgA vasculitis when it accompanies an appropriate small-vessel vasculitis pattern and clinical presentation. Routine histology cannot reliably distinguish this condition from every other cause of leukocytoclastic vasculitis. Immunofluorescence therefore contributes to classification rather than merely repeating the observation of vascular injury. Correlate renal, gastrointestinal and joint findings, while recognizing that deposit detection depends on lesion selection, timing and preservation. A negative result from unsuitable tissue has limited exclusionary value.
Apply it
Purpura, abdominal pain and hematuria accompany leukocytoclastic vasculitis with vascular IgA. Integrate the tissue and systemic findings as evidence supporting IgA vasculitis.
Common pitfall: Neither leukocytoclasia nor IgA staining should be interpreted alone. Deposit distribution, convincing vascular injury and clinical findings determine the strength of classification.
Cutaneous vasculitis and vasculopathy in the era of COVID-19 pandemic · Utility of immunofluorescence in dermatology
12.How should paired biopsies be selected for suspected cutaneous small-vessel vasculitis?
When immune-complex vasculitis is suspected, select an early, partially blanchable macule for direct immunofluorescence to capture immunoglobulin deposits before they diminish. Select a separate, non-necrotic lesion for routine histology whose morphology is likely to demonstrate established vessel-wall injury, often a palpable purpuric papule. Histology seeks mural inflammation and damage; DIF identifies deposited immunoreactants. Match depth to suspected vessel involvement: include adequate dermis for dermal small vessels and subcutis when deeper or medium-vessel disease is suspected. Record the age and site of each sample separately. Submit histology in formalin and DIF by the laboratory-approved method. The specific DIF selection cue is supported by the [EADV position statement](https://pubmed.ncbi.nlm.nih.gov/41399325/).
Apply it
Choose an early, partially blanchable macule for DIF and a separate palpable, non-necrotic purpuric lesion for histology. Label each lesion's age, site and transport method; request sufficient depth for the clinical vascular pattern.
Common pitfall: The same lesion age need not optimize both tests. Necrotic centers can obscure primary injury, older lesions can lose deposits, and a shallow biopsy cannot assess suspected deep vascular disease.
Utility of immunofluorescence in dermatology · Cutaneous vasculitis and vasculopathy in the era of COVID-19 pandemic
13.How do sarcoidal, necrobiotic and foreign-body granulomatous patterns differ?
Sarcoidal granulomas are compact epithelioid aggregates with relatively sparse surrounding lymphocytes. Necrobiotic patterns organize histiocytes around altered collagen; palisading or interstitial histiocytes with dermal mucin support granuloma annulare. Foreign-body granulomas contain giant cells associated with endogenous or exogenous material, sometimes demonstrable by polarization. These patterns guide investigation rather than independently establish cause. Examine for organisms, necrosis, neural involvement and foreign material because infections can resemble noninfectious granulomatous disorders.
Apply it
An annular plaque contains interstitial histiocytes, altered collagen and mucin. Compare granuloma annulare with infectious and foreign-body alternatives using the entire tissue pattern.
Common pitfall: Noncaseating granulomas do not establish sarcoidosis. Negative organism stains also cannot universally exclude infection, particularly when the organism burden is low or sampling is limited.
Dermatopathology Content Specifications — 12/2025 · CDC — Clinical Testing and Diagnosis for Leprosy
26.How does the level of eccrine-duct obstruction determine the morphology of miliaria crystallina and miliaria rubra?
Miliaria crystallina results from obstruction of the eccrine duct within the stratum corneum, producing superficial sweat retention and tiny, clear, flaccid vesicles that rupture easily. Histology shows an intracorneal vesicle with an orthokeratotic roof centered on an acrosyringium, the intraepidermal eccrine duct. Little inflammation accompanies the clear vesicles. Miliaria rubra involves deeper epidermal obstruction with sweat leakage and an inflammatory response, producing erythematous papules and papulovesicles or pustules. The official specifications place miliaria crystallina under Inflammatory Reaction Patterns → Vesiculobullous Reaction Pattern → Intracorneal/Subcorneal Blisters and Pustules. Eccrine anatomy explains its mechanism and provides an anatomic cross-reference.
Apply it
Consider a hospitalized patient who develops painless, nonpruritic, clear vesicles across the chest after fever and profuse sweating. An intracorneal blister centered on an acrosyringium supports miliaria crystallina. Erythematous duct-associated lesions with deeper epidermal involvement favor miliaria rubra. Neutrophil-filled subcorneal pustules instead suggest a pustular process such as acute generalized exanthematous pustulosis; keratinocyte multinucleation and chromatin margination support herpesvirus infection.
Common pitfall: Neither sweating nor nonspecific epidermal edema establishes miliaria. Match the clinical lesion to the blister level and its relationship to the eccrine duct. The minimal inflammation of crystallina does not change its official placement within inflammatory reaction patterns. Its eccrine mechanism should not be counted as separate coverage of the issuer's listed appendage disorders. This selective concept supplements the official content specifications, which define the full examination scope.
Dermatopathology Content Specifications — 12/2025 · Clear vesicular eruption in the intensive care unit - PMC
The EpidermisWritten/practical 5%; virtual microscopy 4%
14.What microscopic structure supports porokeratosis?
A cornoid lamella is a narrow column of parakeratosis associated with focal loss or attenuation of the underlying granular layer and dyskeratotic or vacuolated keratinocytes. In an appropriate clinical and architectural setting, it supports porokeratosis. The structure may be focal and missed in limited sections. Correlate its position with the peripheral keratotic ridge and assess the surrounding epidermis rather than treating any isolated column of parakeratosis as a complete diagnosis.
Apply it
A raised annular rim contains a sharply localized parakeratotic column over hypogranulosis and altered keratinocytes. Use the coordinated findings to support porokeratosis.
Common pitfall: A small parakeratotic column is not universally specific. Underlying epidermal changes, location and the clinical architecture determine whether porokeratosis is the best interpretation.
Porokeratosis: A differential diagnosis to consider in benign lichenoid keratosis
15.How should an annular lesion be sampled when porokeratosis is suspected?
The diagnostic cornoid lamella corresponds to the keratotic peripheral ridge. Sampling only the center of an annular lesion can therefore miss the defining structure. Include the clinically raised edge and communicate the suspected diagnosis. If initial sections show only inflammation or lichenoid change, additional levels may reveal a focal lamella when the relevant edge is already present. Sampling strategy determines whether the specimen can answer the diagnostic question before any microscopic interpretation begins.
Apply it
A central punch shows lichenoid inflammation without a cornoid lamella. Review whether the ridge was included and direct any further biopsy toward the raised border.
Common pitfall: Additional levels cannot recover an edge that was never sampled. A negative center-only biopsy can reflect an anatomic limitation rather than absence of porokeratosis.
Porokeratosis: A differential diagnosis to consider in benign lichenoid keratosis
16.How do melanocytes and keratinocytes cooperate in epidermal pigmentation?
Melanocytes synthesize melanin within melanosomes and transfer pigment to neighboring keratinocytes. Much of the visible epidermal pigment therefore resides in keratinocytes rather than identifying melanocytes themselves. This separates pigment production and transfer from melanocyte number or neoplasia. In a pigmented specimen, determine which cells contain pigment and whether there is a true melanocytic proliferation. Increased pigment alone does not establish increased melanocyte density, abnormal nesting or a melanocytic tumor.
Apply it
Basal keratinocytes contain abundant pigment without increased melanocytes or abnormal nests. Interpret the cellular distribution before attributing the dark appearance to a melanocytic proliferation.
Common pitfall: Pigment within a keratinocyte does not change its lineage. Pigment quantity and melanocytic proliferation require different observations and should be described separately.
The DermisWritten/practical 7%; virtual microscopy 5%
17.Which dermal changes favor morphea, including its early inflammatory phase?
Established morphea is supported by thickened, homogenized dermal collagen with loss or entrapment of normal adnexal structures. Altered architecture is more discriminating than collagen eosinophilia alone. Early lesions may contain superficial and deeper lymphocytes, occasionally resembling patch-stage mycosis fungoides before sclerosis is conspicuous. Progressive collagen replacement around appendages and vessels, together with subsequent clinical induration, redirects interpretation toward morphea. Assess the full dermis and deeper tissue when indicated, comparing initial and later specimens if the clinical course changes.
Apply it
An initially equivocal lymphocytic patch becomes indurated. Broad collagen bundles replacing normal periadnexal spaces on a deeper specimen support an evolving sclerosing process.
Common pitfall: Epidermotropic lymphocytes are not exclusive to mycosis fungoides. Conversely, thick collagen without appropriate architectural and clinical changes is insufficient to establish morphea.
Early morphea simulating patch-stage mycosis fungoides in two cases
18.Which elastic-tissue findings support pseudoxanthoma elasticum?
Pseudoxanthoma elasticum characteristically shows short, clumped, fragmented and mineralized elastic fibers in the mid dermis. An elastic stain demonstrates the abnormal fiber architecture; von Kossa staining highlights associated mineral deposition. The conjunction of elastic-fiber abnormalities and mineralization is more discriminating than either nonspecific fragmentation or dermal calcium alone. Correlate flexural papules and skin laxity with ocular and vascular findings because the tissue pattern can reflect a multisystem disorder. Primary tissue evidence is provided by the [optical-microscopy study of affected skin](https://pmc.ncbi.nlm.nih.gov/articles/PMC7505829/).
Apply it
A flexural papule contains basophilic middermal clumps. Demonstrate fragmented elastic fibers and their mineralization rather than interpreting the clumps as altered collagen.
Common pitfall: Elastic fragmentation alone does not establish pseudoxanthoma elasticum. Confirm the mineralized elastic-fiber relationship and integrate the clinical distribution and systemic phenotype.
19.How is cutaneous amyloid demonstrated histologically?
Amyloid appears as extracellular eosinophilic material, but routine morphology can overlap with other hyaline deposits. Congo red staining with characteristic apple-green birefringence under polarized light supports identification. Confirm that the polarized finding corresponds to the suspected deposits and assess their location and amount. Demonstrating amyloid establishes the nature of the material. It does not independently determine its precursor protein, the clinical form of amyloidosis or whether the patient has systemic disease.
Apply it
Small papillary dermal deposits accompany a pruritic pigmented eruption. Confirm amyloid using Congo red and polarization, then interpret distribution and clinical phenotype separately.
Common pitfall: Eosinophilic material alone is insufficient. Even confirmed amyloid requires further classification before conclusions about biochemical type or systemic involvement can be justified.
Primary Cutaneous Amyloidosis: A Clinical, Histopathological and Immunofluorescence Study
20.Which combination distinguishes scleromyxedema from an incidental increase in dermal mucin?
The classic scleromyxedema pattern combines dermal mucin deposition, fibroblast proliferation and fibrosis. Mucin separates collagen bundles, while increased fibroblasts and collagen remodeling establish a fibromucinous process. Interpret this triad with the generalized papular and sclerodermoid phenotype. Mucin alone is insufficient because it accompanies several inflammatory and metabolic disorders. Some scleromyxedema specimens instead show an interstitial granuloma-annulare-like pattern, making clinical correlation particularly important. These patterns were documented in a [34-patient primary histopathologic study](https://pubmed.ncbi.nlm.nih.gov/26897387/).
Apply it
Widespread firm papules and skin thickening accompany dermal mucin, increased fibroblasts and fibrosis. The coordinated findings favor scleromyxedema over a nonspecific mucin increase.
Common pitfall: A mucin-rich interstitial pattern can resemble granuloma annulare. Neither mucin quantity nor one histologic pattern establishes the diagnosis without the corresponding clinical phenotype.
Normal SkinWritten/practical 3%; virtual microscopy 2%
21.Which features distinguish eccrine from apocrine glands?
Eccrine glands have coiled secretory portions with relatively small lumina and ducts opening onto the skin surface. Apocrine glands have larger secretory lumina, apical secretory protrusions and generally drain into hair follicles in characteristic regions. Distinguish secretory portions from ducts because their epithelial appearances differ. Recognizing normal glandular architecture and regional distribution prevents conspicuous but ordinary appendages from being mistaken for a cystic lesion or abnormal adnexal proliferation.
Apply it
An axillary specimen contains broad-lumened coiled glands with apical protrusions near follicles. Identify normal apocrine differentiation before interpreting gland size as evidence of a tumor.
Common pitfall: Large lumina alone do not establish neoplasia. Regional anatomy, epithelial organization and relationships to follicles are necessary parts of the interpretation.
22.How are Meissner and Pacinian corpuscles distinguished?
Meissner corpuscles are superficial tactile structures within dermal papillae of glabrous skin. Pacinian corpuscles are larger, deeply situated pressure and vibration receptors with concentric lamellae surrounding a central nerve element. Their characteristic locations and architecture distinguish them from each other and from neural proliferations. When an unfamiliar rounded structure appears in a specimen, orient it within the skin layers and identify its internal organization before considering ancillary tests or a neoplastic diagnosis.
Apply it
A deep acral specimen contains an onion-like lamellar structure around a central nerve. Recognize a Pacinian corpuscle from its architecture and expected depth.
Common pitfall: A normal sensory organ can appear masslike in cross-section. Its prominence in one section does not independently establish a cyst or neural tumor.
ArtifactsWritten/practical 3%; virtual microscopy 1%
23.When should an unexpected malignant fragment raise concern for a tissue floater?
A tissue floater is extraneous material introduced during processing or slide preparation. Concern increases when a malignant fragment is detached, anatomically incoherent or sharply discordant with the main specimen and clinical setting. These findings justify investigation rather than automatic acceptance or dismissal. Compare deeper sections, the tissue block and relevant laboratory records to assess continuity and possible carryover. Establishing tissue identity is essential before an unexpected fragment changes the diagnosis or triggers treatment.
Apply it
A granulomatous biopsy contains a tiny detached squamous carcinoma fragment without epithelial continuity. Investigate levels, block findings and possible carryover before finalizing a consequential diagnosis.
Common pitfall: Discordance is not proof of contamination. A genuine second lesion or fragmented invasive focus remains possible until the tissue relationship has been investigated.
Benign Granuloma Masquerading as Squamous Cell Carcinoma Due to a Floater
Diseases of Cutaneous AppendagesWritten/practical 7%; virtual microscopy 5%
24.Which follicular findings support alopecia areata across different stages?
Active alopecia areata commonly shows lymphocytes around and within anagen bulbs, accompanied by bulbar injury, increased catagen or telogen follicles, pigment abnormalities and miniaturization. Chronic or less active lesions may retain miniaturization and altered cycling with sparse peribulbar inflammation. Preserved follicular structures support a nonscarring process. Horizontal sections survey follicular size, density and cycling; suitable deep levels are necessary to assess bulbs. Correlate the inflammatory compartment and cycling changes with the clinical distribution rather than requiring a conspicuous inflammatory cuff in every lesion.
Apply it
Recent patchy loss with bulbar lymphocytes supports active alopecia areata. In a longstanding patch with sparse inflammation, inspect bulb levels, altered cycling and follicular preservation before excluding it.
Common pitfall: Perifollicular and peribulbar are different observations. A section without bulbs cannot assess bulbar inflammation, and miniaturization alone does not distinguish alopecia areata from other nonscarring alopecias.
‘Ho-ver’ing Over Alopecia Areata: Histopathological Study of 50 Cases
25.How does hidradenitis suppurativa differ from a primary isolated apocrine-gland inflammation?
Hidradenitis suppurativa commonly shows follicular hyperkeratosis and occlusion, follicular inflammation and rupture, followed by abscesses, epithelialized tunnels and scarring. Apocrine glands may become secondarily involved, but inflammation centered exclusively on those glands does not explain the disease's usual architecture. Histology varies with stage, so identify the relationship among plugged follicles, ruptured epithelial structures and tunnels. Recurrent lesions in characteristic intertriginous sites supply essential clinical context. Primary support includes the [60-specimen histology study](https://pubmed.ncbi.nlm.nih.gov/8647993/) and a [study of early follicular changes](https://pubmed.ncbi.nlm.nih.gov/19659829/).
Apply it
An axillary excision contains occluded follicles, ruptured cystic structures, suppuration and epithelialized tunnels. Integrate this pattern with recurrent draining nodules to support hidradenitis suppurativa.
Common pitfall: An abscess alone is nonspecific. A late scarred specimen may obscure the initial follicular process, and apocrine involvement does not establish that the gland was the primary target.
27.Which findings distinguish lymphocytic scarring alopecias from alopecia areata?
Lichen planopilaris favors lichenoid upper-follicular injury, perifollicular fibrosis and sebaceous-gland loss. Discoid lupus can also damage follicles but is favored by broader periadnexal inflammation, basement-membrane thickening and dermal mucin. Both can replace follicles with scar. Alopecia areata primarily targets bulbs and preserves the follicular apparatus. Identify the damaged compartment and evidence of permanent structural loss before classifying the process, because an inflammatory scalp biopsy alone does not distinguish scarring from nonscarring disease.
Apply it
Upper-follicular interface injury and sebaceous loss require a scarring-alopecia differential. Mucin and inflammation around additional appendages strengthen consideration of discoid lupus.
Common pitfall: Late scarred centers may lose distinguishing inflammation. An active margin is more informative for identifying the initiating injury than a completely destroyed follicular population.
Dermatopathology Content Specifications — 12/2025 · ‘Ho-ver’ing Over Alopecia Areata: Histopathological Study of 50 Cases
Cysts, Sinuses and PitsWritten/practical 3%; virtual microscopy 2%
28.Which keratinization pattern distinguishes a trichilemmal cyst from an infundibular cyst?
A trichilemmal cyst shows abrupt keratinization without an intervening granular layer, producing compact luminal keratin. An infundibular cyst resembles epidermal infundibular epithelium, with a granular layer and laminated keratin. Evaluate an intact portion of the wall because rupture and inflammation can obscure the distinction. Assess proliferation, atypia and infiltrative growth separately. Abrupt keratinization establishes a differentiation pattern but does not alone establish a proliferating tumor or malignant behavior.
Apply it
An intact scalp cyst has abrupt conversion of squamous cells to compact keratin without a granular layer. Favor trichilemmal differentiation and assess solid proliferative areas independently.
Common pitfall: Scalp location is supportive rather than diagnostic. Keratinization type cannot replace evaluation of growth pattern, cytologic atypia and tissue invasion when a proliferating lesion is suspected.
Imaging findings of trichilemmal cyst and proliferating trichilemmal tumour
PanniculitisWritten/practical 3%; virtual microscopy 5%
29.Which panniculitis pattern supports erythema nodosum?
Erythema nodosum classically produces predominantly septal panniculitis without primary vasculitis. Septal edema, inflammation and later fibrosis vary with lesion age, and inflammation may extend beyond sharply defined septal boundaries. Identify the dominant compartment and evaluate vessels rather than demanding a completely pure pattern. Clinically similar tender nodules can represent other diseases. Histology must therefore be reconciled with lesion distribution, evolution and systemic setting before the clinical label is accepted.
Apply it
Tender pretibial nodules show expanded inflamed septa without convincing wall destruction. Favor erythema nodosum when adequate subcutis and the clinical findings support that interpretation.
Common pitfall: Tender leg nodules are not automatically erythema nodosum. A predominantly lobular or vasculitic pattern should redirect the differential rather than be forced into the initial label.
Erythema Nodosum: Clinicopathologic Correlations and Their Use in Differential Diagnosis
30.How does specimen depth determine the reliability of panniculitis classification?
Panniculitis classification requires representative subcutaneous lobules, septa and vessels. A superficial specimen may contain only nonspecific dermal inflammation or a small unrepresentative edge of fat, making septal-versus-lobular assignment unreliable. Obtain adequate subcutis and interpret lesion age alongside compartmental distribution and vascular injury. Distinguish an observed pattern from a limitation caused by insufficient anatomy. A narrowly sampled fragment can suggest a process without demonstrating its dominant compartment or excluding deeper vascular involvement.
Apply it
A superficial punch from a deep nodule contains minimal fat. Explain why classification is limited and obtain tissue that permits assessment of subcutaneous compartments and vessels.
Common pitfall: More stains cannot replace absent anatomy. Deeper levels help only when representative subcutis is already present somewhere within the tissue block.
Erythema Nodosum: Clinicopathologic Correlations and Their Use in Differential Diagnosis
Metabolic and Storage DiseasesWritten/practical 3%; virtual microscopy 5%
31.What mechanism produces porphyria cutanea tarda, and how is it distinguished from pseudoporphyria?
Porphyria cutanea tarda results from reduced hepatic uroporphyrinogen decarboxylase activity. Iron-dependent oxidation generates uroporphomethene, an inhibitor of that enzyme, contributing to accumulation of highly carboxylated porphyrins. Circulating photoreactive porphyrins explain sun-exposed skin fragility and blistering. Histology may show a cell-poor subepidermal blister and papillary festooning. Pseudoporphyria can share these clinical and microscopic findings but lacks the characteristic biochemical porphyrin abnormality. Confirmation therefore requires porphyrin testing. Review relevant medications and exposures when assessing the mimic.
Apply it
Dorsal-hand fragility with a minimally inflamed subepidermal blister warrants porphyrin testing. Histology supports a porphyria-like process but cannot establish the metabolic distinction.
Common pitfall: Festooning, sparse inflammation and photodistribution are shared findings. They cannot substitute for biochemical confirmation or demonstrate the enzyme defect by themselves.
A porphomethene inhibitor of uroporphyrinogen decarboxylase causes porphyria cutanea tarda - PMC · Porphyria cutanea tarda: A unique iron-related disorder
32.Which epidermal pattern should raise concern for zinc-deficiency dermatitis?
Zinc deficiency can produce parakeratosis, epidermal pallor and vacuolar injury, with superficial epidermal cleavage or detachment and variable intraepidermal edema. Periorificial or acral dermatitis in a patient with malnutrition, malabsorption or inadequately supplemented artificial nutrition strengthens the hypothesis. This is a nutritional injury pattern rather than a histologically unique diagnosis: glucagonoma-associated necrolytic migratory erythema and other deficiency states can overlap. Assess nutritional history and biochemical findings. Primary support includes [zinc deficiency during parenteral alimentation](https://pubmed.ncbi.nlm.nih.gov/6456952/) and a [case demonstrating overlap with glucagonoma dermatitis](https://pubmed.ncbi.nlm.nih.gov/6464530/).
Apply it
A patient receiving prolonged artificial nutrition develops acral and periorificial erosive plaques with parakeratosis and epidermal degeneration. Investigate zinc provision and deficiency rather than assigning eczema from edema alone.
Common pitfall: A necrolytic epidermal pattern does not identify one nutrient or establish a glucagonoma. The distribution, nutritional context and laboratory assessment determine its interpretation.
Infections and InfestationsWritten/practical 14%; virtual microscopy 16%
33.How do complementary serologic tests clarify discordant syphilis results?
Treponemal antibodies can persist after treatment, while quantitative nontreponemal testing helps assess activity and follow response in context. In a reverse-sequence algorithm, a reactive treponemal screen is followed by quantitative nontreponemal testing. If that result is nonreactive, a second treponemal assay using a different format or antigen set adjudicates discordance. Interpret the sequence with prior treatment and recent exposure. Neither a reactive treponemal screen nor a plasma-cell-rich biopsy independently establishes new active infection.
Apply it
A previously treated patient has a reactive treponemal screen and nonreactive nontreponemal test. Review exposure and treatment history and obtain the different treponemal assay.
Common pitfall: Discordance can reflect treated infection, early infection or false reactivity. It has no single universal explanation independent of history and the complete testing sequence.
CDC Laboratory Recommendations for Syphilis Testing, United States, 2024
34.Which tissue method is recommended for suspected cutaneous syphilis?
CDC recommends immunohistochemistry for direct detection of Treponema pallidum in formalin-fixed, paraffin-embedded tissue. Silver staining is no longer recommended for this purpose because of low sensitivity and interpretive difficulties. Plasma cells and endothelial changes can raise suspicion but are not diagnostic. Interpret a validated immunostain by its tissue distribution and correlate with serology and clinical findings. A negative tissue stain cannot independently exclude infection when low organism burden or sampling limits detection.
Apply it
A rash biopsy contains plasma cells and endothelial swelling. Select validated Treponema pallidum immunohistochemistry and appropriate serology rather than treating the inflammatory pattern as confirmation.
Common pitfall: Darkfield examination requires suitable fresh lesion material rather than routine paraffin sections. Different direct-detection methods have different specimen requirements and cannot be interchanged indiscriminately.
CDC Laboratory Recommendations for Syphilis Testing, United States, 2024
35.How should superficial fungal infection be distinguished from inflammatory dermatitis?
Tinea can produce parakeratosis, compact cornified layers, mild spongiosis and cornified-layer neutrophils, overlapping with eczema and psoriasis. These findings should trigger a search for fungi and PAS staining when appropriate. Demonstrated fungal structures provide stronger evidence than the inflammatory reaction. A [103-case study of PAS-positive tinea](https://pubmed.ncbi.nlm.nih.gov/27264960/) documented these clues and substantial clinical underrecognition. Interpret organism morphology and location without claiming species identification from a broad fungal stain.
Apply it
An annular scaly plaque shows spongiosis and cornified-layer neutrophils. Examine the stratum corneum with PAS before concluding that the reaction is eczema or psoriasis.
Common pitfall: Neutrophilic scale suggests a search but does not prove infection. Conversely, a mild nonspecific reaction does not exclude fungi when appropriate structures have not been sought.
36.Why is cutaneous nerve involvement a discriminating clue for leprosy?
Leprosy characteristically involves peripheral nerves, making sensory loss within a lesion and histologic involvement of dermal nerves important discriminators. Inflammation or organisms associated with nerves should prompt targeted evaluation even when the broader pattern is nonspecific. Biopsy an active patch edge, assess cutaneous nerves and use appropriate acid-fast staining, commonly Fite. Reference-laboratory molecular testing can add evidence when needed. Bacillary burden varies across the spectrum, so inconspicuous organisms do not exclude the disease.
Apply it
An enlarging anesthetic patch contains inflammation involving a dermal nerve. Communicate concern for leprosy and combine representative tissue studies with neurologic examination.
Common pitfall: Random inactive-site sampling may miss the informative neural relationship. A nonspecific granulomatous pattern or absent conspicuous bacilli cannot independently close the differential.
CDC — Clinical Testing and Diagnosis for Leprosy · Mycobacterium lepromatosis Lepromatous Leprosy — Figure 2
37.Which findings support a multibacillary lepromatous pattern?
A lepromatous pattern can show diffuse dermal foamy histiocytes containing numerous acid-fast organisms, including clustered bacilli. Neural involvement provides additional support. Fite staining helps demonstrate tissue organisms. The combination establishes a heavily bacillated pattern in the appropriate clinical setting, but morphology alone should not assign a particular mycobacterial species. Bacillary abundance, cellular response and neural distribution describe the tissue process; species identification requires suitable additional evidence rather than inference from organism number.
Apply it
Diffuse papules contain foamy macrophages and numerous Fite-positive bacilli involving cutaneous nerves. Recognize a multibacillary leprosy pattern while keeping species assignment separate.
Common pitfall: Foamy histiocytes are nonspecific, and acid-fast positivity alone does not determine species. Combine organism distribution, nerve involvement, clinical findings and indicated confirmatory studies.
Mycobacterium lepromatosis Lepromatous Leprosy — Figure 2 · CDC — Clinical Testing and Diagnosis for Leprosy
38.Which cytopathic findings support cutaneous herpesvirus infection?
Herpetic epithelial injury can show multinucleation, nuclear molding and chromatin margination, often with ballooning, acantholysis and intraepidermal vesiculation. Examine viable epithelium at an ulcer edge because a denuded center may lack infected keratinocytes. Shared histology cannot reliably distinguish herpes simplex virus from varicella-zoster virus. Virus-specific immunohistochemistry or validated molecular testing addresses that distinction. A [primary comparative immunohistochemical study](https://pubmed.ncbi.nlm.nih.gov/8385379/) demonstrated that specific antibody labeling could distinguish these infections despite their histologic similarity.
Apply it
An ulcer edge contains multinucleated keratinocytes with molded nuclei and peripheral chromatin. Pursue virus-specific testing rather than classifying the virus from the shared cytopathy.
Common pitfall: A denuded ulcer can be nondiagnostic for viral cytopathy. An immunostain's viral specificity must be established before its result is used to distinguish HSV from VZV.
39.Which findings support Cryptococcus, and what do they establish about disease extent?
Cryptococcus may appear as round-to-oval budding yeasts with capsules producing clear halos on routine sections. Mucicarmine can highlight the polysaccharide capsule, while fungal stains demonstrate organisms. Together these findings support cryptococcal tissue infection more strongly than a halo alone. The biopsy establishes involvement of the sampled site but does not determine species or distinguish localized from disseminated infection. Immunosuppression makes the finding consequential, and scant tissue inflammation does not imply low clinical risk.
Apply it
A patient receiving a tumor necrosis factor inhibitor has budding yeasts with mucicarmine-positive capsules. Communicate the finding and integrate microbiology with assessment for extracutaneous disease.
Common pitfall: Clear spaces can be artifactual. Neither a solitary visible lesion nor mild inflammation establishes that cryptococcal infection is confined to skin.
40.What distinguishes direct evidence of scabies from its inflammatory reaction?
A mite, egg or fecal pellet within a stratum-corneum burrow supplies direct evidence of infestation. The IACS confirmed-scabies category includes microscopic visualization of mites, eggs or feces in skin samples. Spongiosis and eosinophilic inflammation alone are nonspecific and do not meet that direct-visualization criterion. Target a suspicious burrow for examination rather than assuming a routine rash biopsy will contain the organism. Negative microscopy does not exclude scabies because sensitivity depends on site selection and sampling. These distinctions follow the [IACS consensus criteria](https://pmc.ncbi.nlm.nih.gov/articles/PMC7687112/).
Apply it
An intensely pruritic eruption has nonspecific spongiosis. Use distribution and contact history to locate a suspicious burrow, then seek a mite, egg or fecal pellet directly.
Common pitfall: Eosinophils neither confirm nor exclude infestation. A negative sample and a confirmed absence of scabies are different conclusions.
41.Why does follicular involvement change assessment of dermatophytosis?
Dermatophytes can involve follicular keratin as well as the surface stratum corneum. When the infected follicular wall is disrupted, organisms and follicular contents can provoke suppurative or granulomatous inflammation in the surrounding dermis, supporting Majocchi granuloma in the appropriate setting. Distinguish organisms confined to keratin from demonstrated deeper infection and its tissue response. Examine follicular profiles with fungal stains and obtain microbiologic identification when needed. Primary support is provided by a [multicenter retrospective cohort of Majocchi granuloma](https://pmc.ncbi.nlm.nih.gov/articles/PMC10517273/).
Apply it
A persistent plaque contains inflamed follicles. Locate fungal structures relative to follicular walls and the dermis, assess rupture and granulomatous inflammation, and correlate culture findings.
Common pitfall: Fungi within follicular keratin alone do not prove dermal invasion. Surface-negative testing can also miss a deeper follicular process.
TumorsWritten/practical 25%; virtual microscopy 31%
42.How is Breslow thickness measured in invasive melanoma?
Breslow thickness is measured perpendicularly from the top of the epidermal granular layer, or from the base of a true ulcer, to the deepest invasive melanoma cell. It measures invasive depth rather than the lateral extent of an in situ component. Accurate orientation and identification of the deepest focus are essential. A partial or transected specimen can limit assessment, and the report must distinguish a measured visible depth from a securely established maximum tumor thickness.
Apply it
An oriented specimen has intact epidermis and a deepest invasive focus. Measure perpendicular to the surface from the granular layer and document relevant sampling limitations.
Common pitfall: The stratum corneum is the wrong reference point. Oblique measurement and confusion between in situ extension and invasion can also produce an incorrect thickness.
43.How should a deeply transected melanoma be reported?
When invasive melanoma reaches the deep specimen edge, the measured thickness is a minimum rather than a known maximum. Report the observed depth with an explicit limitation, commonly expressed as at least, and document deep-margin involvement. Unobserved tumor could alter the completed thickness assessment. Thickness, ulceration, mitotic activity and margins remain separate report elements. Qualify the element affected by sampling while recording other evaluable findings rather than treating the entire specimen as uninformative.
Apply it
A shave contains melanoma reaching the deep edge at 0.7 mm. Report at least 0.7 mm with deep transection rather than presenting a completed maximum measurement.
Common pitfall: A precise decimal does not resolve incomplete sampling. Deep transection makes the measured value a lower bound even when the visible tumor appears thin.
44.Which epidermal defect counts as melanoma ulceration?
Melanoma ulceration requires loss of the epidermis over tumor with an associated host response, interpreted as tumor related rather than procedural or unrelated traumatic damage. Fibrin and inflammation can support a true ulcer, but the tissue context is essential. An epidermal gap created during biopsy or sectioning should not automatically be recorded as ulceration. When previous intervention or poor preservation prevents reliable assessment, communicate that limitation rather than forcing an unsupported present-or-absent conclusion.
Apply it
A surface defect with fibrin overlies melanoma at a previously sampled site. Assess the relationship to the earlier procedure before assigning tumor-related ulceration.
Common pitfall: Absent epidermis alone is insufficient. Trauma, previous biopsy and processing damage can mimic a prognostically meaningful ulcer and must be distinguished where possible.
45.Which findings support basal cell carcinoma over squamous carcinoma or a benign follicular tumor?
Basaloid nests with peripheral palisading and stromal clefting support basal cell carcinoma. Keratinizing atypical squamous cells and intercellular bridges favor squamous differentiation. BerEP4 can support basal cell carcinoma over conventional squamous carcinoma, but benign follicular tumors can also stain. A [primary comparative study](https://pubmed.ncbi.nlm.nih.gov/37275796/) found BerEP4 expression in basal cell carcinomas and several follicular tumors, demonstrating this limitation. Evaluate architecture, stromal relationships and follicular differentiation; a limited sample may omit the decisive interface.
Apply it
A facial lesion contains palisaded basaloid nests with stromal retraction. Interpret BerEP4 within the epithelial and follicular differential rather than using positivity as an independent diagnosis.
Common pitfall: BerEP4 is not specific for basal cell carcinoma across all cutaneous tumors. Study-specific staining results do not establish universal sensitivity or specificity for every variant.
46.How are architecture, phenotype and molecular findings integrated in dermatofibrosarcoma protuberans?
Dermatofibrosarcoma protuberans commonly shows uniform spindle cells, storiform architecture and honeycomb infiltration of subcutaneous fat, often with broad CD34 expression. CD34 alone is insufficient. Fibrosarcomatous areas may develop cellular fascicles or herringbone architecture, greater atypia and mitotic activity, and reduced or absent CD34. Compare transitions with conventional tumor. A characteristic COL1A1–PDGFB fusion can support difficult cases, while a negative assay must be interpreted with tissue quality, assay coverage and possible variant alterations.
Apply it
A storiform CD34-positive tumor infiltrates fat and transitions into a cellular fascicular CD34-poor region. Assess fibrosarcomatous change and use appropriate molecular testing if classification remains uncertain.
Common pitfall: Bland nuclei do not establish benign behavior, fat infiltration alone does not establish transformation, and CD34 loss does not exclude a transformed component.
Pediatric dermatofibrosarcoma protuberans: Clinicopathologic and genetic analysis of 66 cases
47.Which architecture supports syringoma?
Syringoma contains small epithelial ducts and cords in a fibrous dermal stroma, often with comma-shaped or tadpole-like extensions. Bland cytology and a relatively superficial, limited proliferation favor the diagnosis. Interpret the ductal structures within the lesion's overall silhouette; a tiny superficial fragment cannot demonstrate the complete depth. Primary examples document [characteristic ductal morphology](https://pubmed.ncbi.nlm.nih.gov/34046271/) and show that solitary syringomas are generally more superficial than histologically similar microcystic adnexal carcinomas in a [comparative series](https://pubmed.ncbi.nlm.nih.gov/8599451/).
Apply it
A small papule contains bland tadpole-shaped ducts in superficial dermis. Confirm that the sampled architecture is limited and lacks a deeply infiltrative component.
Common pitfall: Ducts in a sclerotic stroma do not independently establish benignity. A superficial biopsy may resemble syringoma while omitting a deeper carcinoma.
48.Which findings distinguish microcystic adnexal carcinoma from a superficial benign ductal proliferation?
Microcystic adnexal carcinoma combines follicular or keratinizing structures with ductal differentiation in a sclerotic stroma. Its important discriminator is deep infiltrative growth, which can extend through dermis into subcutis and involve nerves despite deceptively bland cells. Adequate depth is therefore essential. A [primary morphologic study](https://pubmed.ncbi.nlm.nih.gov/2187025/) demonstrated combined differentiation and perineural invasion, while a [comparison with solitary syringoma](https://pubmed.ncbi.nlm.nih.gov/8599451/) emphasized deeper and perineural infiltration in carcinoma.
Apply it
A firm facial lesion has bland ducts in sclerosis on a shallow biopsy. Obtain architecture extending to the deep interface when the clinical lesion suggests a larger infiltrative process.
Common pitfall: Cytologic blandness does not exclude carcinoma. A shallow sample cannot establish that a ductal proliferation is superficial or exclude perineural extension.
49.Which immunophenotypic combination supports Merkel cell carcinoma?
Merkel cell carcinoma shows epithelial and neuroendocrine differentiation, commonly with perinuclear dotlike CK20. Broad cytokeratin supports epithelial lineage; synaptophysin, chromogranin or INSM1 supports neuroendocrine differentiation. TTF-1 helps assess pulmonary small-cell carcinoma, while CD45 and SOX10 or S100 address lymphoid and melanocytic alternatives. Merkel cell polyomavirus large-T-antigen staining supports the diagnosis when positive. CK20-negative and virus-negative Merkel cell carcinomas occur. Interpret the panel with morphology and clinical assessment of a possible extracutaneous primary because no individual marker establishes origin.
Apply it
A dermal small-cell tumor expresses cytokeratin, synaptophysin and dotlike CK20 with negative TTF-1. Favor Merkel cell carcinoma when the clinical assessment supports a cutaneous primary; broaden the panel if findings are atypical.
Common pitfall: Shared neuroendocrine staining does not determine origin. Negative CK20 or viral staining does not independently exclude Merkel cell carcinoma.
50.How is invasive squamous cell carcinoma distinguished from an in situ proliferation?
Squamous cell carcinoma in situ shows disordered epithelial maturation and atypical keratinocytes confined to epithelial structures. Invasion requires extension into dermal stroma as atypical nests, strands or cells, sometimes with keratinization and a stromal response. Distinguish adnexal extension of in situ disease from stromal invasion. A shallow or deeply transected biopsy may omit the required interface. A [primary study of transected squamous carcinoma in situ](https://pubmed.ncbi.nlm.nih.gov/25920731/) demonstrated that subsequent assessment can reveal invasion, supporting explicit reporting of this sampling limitation.
Apply it
An atypical squamous proliferation reaches the base of a shallow biopsy. Report that the sample cannot exclude invasion rather than interpreting the absent interface as evidence of confinement.
Common pitfall: Marked atypia does not itself establish invasion. Conversely, failure to see invasion in an incompletely sampled lesion does not establish that the entire lesion is in situ.
51.How are sebaceous differentiation and malignant behavior assessed separately?
Sebaceous differentiation is suggested by cells with multivacuolated cytoplasm and scalloped nuclei; adipophilin can demonstrate lipid-droplet-associated staining in paraffin sections. Evaluate lobular organization, maturation, cytologic atypia and infiltrative growth separately to distinguish benign sebaceous proliferations from carcinoma. Adipophilin supports differentiation but does not establish malignancy and can stain nonsebaceous clear-cell lesions. Primary support includes an [architectural and cytologic study of 63 sebaceous neoplasms](https://pubmed.ncbi.nlm.nih.gov/31584883/) and an [adipophilin study of 117 lesions](https://pubmed.ncbi.nlm.nih.gov/20118912/).
Apply it
A clear-cell epithelial tumor shows lipid-droplet staining. Establish sebaceous differentiation, then assess architecture and invasion before assigning benign or malignant behavior.
Common pitfall: Clear cytoplasm alone is not sebaceous differentiation, and adipophilin positivity alone establishes neither a sebaceous carcinoma nor hereditary susceptibility.
52.Which epidermotropic findings raise concern for mycosis fungoides?
Mycosis fungoides is supported by atypical epidermotropic lymphocytes disproportionate to spongiosis, often with basal alignment and a superficial infiltrate in persistent patches or plaques. Reduced pan-T-cell antigens, including CD7, can strengthen interpretation when the loss corresponds to the suspicious population, particularly within the epidermis. Early lesions can be subtle, and reactive conditions can show epidermotropism or antigen loss. Integrate cytology, distribution, compartment-specific phenotype and longitudinal clinical findings rather than treating any isolated feature as diagnostic.
Apply it
Persistent patches show irregular epidermotropic lymphocytes, little spongiosis and marked epidermal CD7 reduction. The coordinated findings provide stronger support than epidermotropism or antigen loss alone.
Common pitfall: Epidermal lymphocytes and reduced CD7 are not independently diagnostic of lymphoma. Inflammatory mimics remain possible when architecture, cytology or clinical evolution is equivocal.
Mycosis fungoides and Sézary syndrome: Presentation, diagnosis, staging and management
53.Which findings distinguish a conventional nevus from melanoma?
A conventional nevus generally favors symmetry, circumscription, organized nesting and maturation with depth. Melanoma is favored by a coordinated combination of asymmetry, poor circumscription, disordered junctional growth, extensive pagetoid spread, atypia, impaired maturation and concerning mitotic activity. Individual findings overlap. Primary studies assessing [conventional melanoma criteria](https://pubmed.ncbi.nlm.nih.gov/18626309/) and [pagetoid melanocytosis in benign and malignant lesions](https://pubmed.ncbi.nlm.nih.gov/7793477/) support integrated interpretation rather than treating pagetoid cells as an independent diagnosis. Specimen completeness affects assessment of the overall silhouette.
Apply it
Compare the whole lesion and superficial-to-deep maturation before interpreting focal pagetoid cells. Incorporate site, age and previous procedures when assessing a possible benign mimic.
Common pitfall: Pagetoid spread and atypia can occur in benign settings. A partial biopsy can hide asymmetry or prevent reliable assessment of circumscription and maturation.
54.Why is T-cell clonality supportive rather than definitive for mycosis fungoides?
T-cell receptor testing detects a dominant rearrangement rather than malignant behavior itself. Reactive infiltrates can be clonal, while genuine mycosis fungoides can test negative because of limited tumor burden or technical factors. Identical clones in separately sampled suspicious lesions can strengthen evidence but still require clinicopathologic integration. Use clonality to address a focused uncertainty and interpret it with morphology, immunophenotype, lesion distribution and the longitudinal course rather than allowing the molecular result to replace those observations.
Apply it
A mildly atypical patch yields a clonal result. Compare morphology, phenotype and other suspicious sites before deciding whether the combined evidence supports lymphoma.
Common pitfall: Clonal does not automatically mean malignant, and a negative result does not reliably exclude lymphoma. Molecular findings require contextual interpretation in early cutaneous disease.
Combined Use of PCR-Based TCRG and TCRB Clonality Tests on Paraffin-Embedded Skin Tissue in the Differential Diagnosis of Mycosis Fungoides and Inflammatory Dermatoses - PMC · Mycosis fungoides and Sézary syndrome: Presentation, diagnosis, staging and management
55.How do blood-burden thresholds contribute to evaluation for Sézary syndrome?
Flow-cytometric blood classification uses absolute counts of a defined aberrant T-cell population: B0 is fewer than 250 cells/µL, B1 is 250 to fewer than 1,000 cells/µL and B2 is at least 1,000 cells/µL. Do not add overlapping CD7-negative and CD26-negative populations together. A Sézary designation additionally requires the appropriate erythrodermic clinicopathologic presentation and a blood clone matching skin. B2 describes blood burden and can occur in mycosis fungoides without independently establishing Sézary syndrome. The thresholds are supported by the [ISCL–USCLC–EORTC staging statement](https://pmc.ncbi.nlm.nih.gov/articles/PMC9353153/).
Apply it
An erythrodermic patient has 1,400 defined aberrant cells/µL. Recognize B2 blood burden, then establish clonal concordance and integrate the presentation and disease history.
Common pitfall: Percent antigen loss cannot substitute for an absolute count. A skin biopsy alone establishes neither blood burden nor a matching skin–blood clone.
Mycosis fungoides and Sézary syndrome: Presentation, diagnosis, staging and management
56.What does mismatch-repair protein testing in a sebaceous neoplasm establish?
Mismatch-repair protein loss can identify a patient requiring evaluation for hereditary susceptibility, including the Muir–Torre phenotype of Lynch syndrome. Confirm intact internal controls and integrate the loss pattern with personal and family cancer history. Tumor loss is a screening result rather than proof of a germline mutation because somatic abnormalities also occur. Retained staining does not eliminate hereditary risk when multiple sebaceous tumors or a strongly suggestive cancer history warrant genetic assessment.
Apply it
MSH2/MSH6 loss with retained nonneoplastic staining supports genetics evaluation without establishing germline status. Preserve that evaluation despite retained staining when the clinical history remains strongly suggestive.
Common pitfall: Neither abnormal tumor staining nor retained staining independently resolves inherited susceptibility. Genetic counseling and appropriate testing answer the germline question.
Screening for Germline Mismatch Repair Mutations Following Diagnosis of Sebaceous Neoplasm
57.Which findings support nodular hidradenoma?
Nodular hidradenoma is typically a circumscribed dermal epithelial tumor with solid and cystic areas, ductal lumina and variable clear and eosinophilic cell populations. Demonstrating true ducts helps establish sweat-gland differentiation rather than interpreting clear cytoplasm alone. Evaluate the lesion's border and cytologic features separately from its differentiation; the clear-cell component does not itself establish malignancy. Primary support includes a [histopathologic spectrum study](https://pubmed.ncbi.nlm.nih.gov/21993337/) and a [study of ductal and secretory differentiation](https://pubmed.ncbi.nlm.nih.gov/9027630/).
Apply it
A dermal nodule contains solid-cystic epithelial lobules, clear cells and small ducts. Use the combined architecture to support hidradenoma and inspect the full interface for concerning growth.
Common pitfall: A clear-cell tumor is not automatically a hidradenoma or a sebaceous neoplasm. Confirm ductal differentiation and interpret circumscription, atypia and invasion independently.
Laboratory and Special ProceduresWritten/practical 6%; virtual microscopy 0%
58.How should a direct-immunofluorescence specimen be collected and transported?
Direct immunofluorescence requires a site and transport method appropriate to the suspected disease. Perilesional skin is commonly selected for autoimmune blistering evaluation, while other diagnostic questions require different sites. Submit tissue in the laboratory's designated medium or another specifically accepted method rather than routinely placing it in formalin. Before interpreting a negative result, assess location, erosion, treatment and preservation. A technically unsuitable specimen can justify correctly collected repeat testing when the remaining evidence strongly supports disease.
Apply it
For paired blister biopsies, place lesional tissue for histology in formalin and appropriately selected perilesional tissue in the approved fluorescence medium, labeling the sites clearly.
Common pitfall: A correct test request cannot rescue incorrect preservation. Confirm laboratory requirements before collection, especially when transport is delayed or the available medium is uncertain.
59.How should special stains be selected to answer a diagnostic hypothesis?
Select a stain according to the structure or material being tested and define what a positive result can establish. Treponema pallidum immunohistochemistry, mucicarmine for a cryptococcal capsule and Congo red with polarization for amyloid answer different questions. Controls and localization determine interpretability. Complementary stains are useful when their combined results distinguish realistic alternatives. Indiscriminate staining can introduce nonspecific findings without resolving the underlying question, particularly if the specimen lacks the necessary anatomy or target material.
Apply it
Extracellular hyaline deposits prompt Congo red and polarized examination to test for amyloid. Organism stains answer a different hypothesis unless separate findings suggest infection.
Common pitfall: Staining must correspond to the correct structure. Color alone cannot replace knowledge of the target, internal controls, tissue distribution and diagnostic limitations.
CDC Laboratory Recommendations for Syphilis Testing, United States, 2024 · Invasive Cryptococcosis and Adalimumab Treatment — Figure · Primary Cutaneous Amyloidosis: A Clinical, Histopathological and Immunofluorescence Study
Management & Informatics-GeneralWritten/practical 1%; virtual microscopy 0%
60.How should a suspected tissue-contamination error be investigated and prevented?
Suspected contamination requires both case-level identity assessment and process-level investigation. Review the discrepancy, compare slides and block findings, and examine relevant processing or preparation records to identify a plausible carryover point. Correct affected interpretation through the laboratory's communication process. Root-cause analysis then asks how the workflow permitted the event and which measurable change could reduce recurrence. Distinguish an evidence-supported failure mechanism from an assumption about individual carelessness, and assess whether the corrective action addresses that mechanism.
Apply it
Resolve the patient's report, trace preparation steps and select a preventive change tied to the demonstrated failure point. Define how recurrence or process performance will be monitored.
Common pitfall: Removing a fragment from consideration does not complete improvement. Conversely, a plausible process hypothesis must not be presented as an established cause without supporting evidence.
Benign Granuloma Masquerading as Squamous Cell Carcinoma Due to a Floater · Dermatopathology Content Specifications — 12/2025
What to focus on during revision
The following are CertMedbry study suggestions. Use the official outline to check the full scope of your examination.
- Give substantial slide practice to tumors, inflammatory reaction patterns and infections, reflecting their prominence in both section blueprints.
- Compare reaction patterns using the dominant compartment, architecture, defining cells and distribution of injury.
- Practise epithelial and melanocytic differentials alongside mesenchymal, glandular adnexal and lymphoid tumors.
- Compare collagen, elastic-fiber and mucin abnormalities, and distinguish follicular disease from eccrine-duct disorders.
- Treat depth, orientation, lesion selection and preservation as diagnostic variables.
- Separate clonality from malignancy, tumor screening from germline status, and organism detection from species identification or dissemination.
- Use the official content specifications to study the full scope beyond these selected concepts.
A practical preparation plan
1. Map the full scope
Read the 2026 blueprint beside the final 12/2025 specifications. Maintain separate written/practical and virtual microscopy priorities, and identify additional topics requiring dedicated study.
2. Build a repeatable slide description
State specimen adequacy, dominant compartment, reaction pattern, defining structures and realistic alternatives. Identify the discriminating observation before committing to a diagnosis.
3. Rehearse ancillary-test decisions
For each proposed test, name its target, expected pattern, controls, specimen requirements and the result that would change the differential.
4. Practise practical-image interpretation
Review gross lesions, fluorescence, histochemical, microbiologic and cytologic preparations. Describe the finding before connecting it to a diagnosis and a consequential next decision.
5. Develop virtual microscopy discipline
Scan whole slides systematically, assess deep and peripheral interfaces, and return to suspicious areas at higher power. Compare difficult interpretations with expert review.
6. Convert errors into discriminators
Explain why every alternative fails, record the missed cue and revisit the corresponding pattern. Use flashcards to recall mechanisms and diagnostic boundaries without relying on option recognition.
Use your sample score as a starting point
The free set contains 20 original practice questions. It is a small learning sample, not an official examination or a validated pass prediction. Review each explanation and its source before moving to another topic.
Start the free sampleOfficial sources and updates
- ABD — Dermatopathology
- ABD — Dermatopathology Subspecialty Certification Exam FAQ
- ABPath — Dermatopathology Exam Description
- ABPath — Subspecialty Exam Blueprints and Daily Schedules
- Dermatopathology Exam Blueprint — Updated for 2026
- ABPath — Content Specifications for Examinations
- Dermatopathology Content Specifications — 12/2025
- Psoriasis or not? Review of 51 clinically confirmed cases
- Epidermolysis Bullosa Acquisita: A Report of Four Cases
- Utility of immunofluorescence in dermatology
- Cutaneous vasculitis and vasculopathy in the era of COVID-19 pandemic
- CDC Laboratory Recommendations for Syphilis Testing, United States, 2024
- CDC — Clinical Testing and Diagnosis for Leprosy
- Mycobacterium lepromatosis Lepromatous Leprosy — Figure 2
- Invasive Cryptococcosis and Adalimumab Treatment — Figure
- CAP — Current Cancer Protocols
- CAP Invasive Melanoma of the Skin: Biopsy — Version 1.1.0.0
- Pediatric dermatofibrosarcoma protuberans: Clinicopathologic and genetic analysis of 66 cases
- NCCN Merkel Cell Carcinoma Guidelines — Version 2.2026
- Mycosis fungoides and Sézary syndrome: Presentation, diagnosis, staging and management
- Screening for Germline Mismatch Repair Mutations Following Diagnosis of Sebaceous Neoplasm
- Porokeratosis: A differential diagnosis to consider in benign lichenoid keratosis
- Early morphea simulating patch-stage mycosis fungoides in two cases
- Histology of Skin — MedCell
- ‘Ho-ver’ing Over Alopecia Areata: Histopathological Study of 50 Cases
- Imaging findings of trichilemmal cyst and proliferating trichilemmal tumour
- Erythema Nodosum: Clinicopathologic Correlations and Their Use in Differential Diagnosis
- Porphyria cutanea tarda: A unique iron-related disorder
- Benign Granuloma Masquerading as Squamous Cell Carcinoma Due to a Floater
- Primary Cutaneous Amyloidosis: A Clinical, Histopathological and Immunofluorescence Study
- A porphomethene inhibitor of uroporphyrinogen decarboxylase causes porphyria cutanea tarda - PMC
- Combined Use of PCR-Based TCRG and TCRB Clonality Tests on Paraffin-Embedded Skin Tissue in the Differential Diagnosis of Mycosis Fungoides and Inflammatory Dermatoses - PMC
- HJMPH_Nov17Suppl2.pdf
- 2026_DP-Exam-Schedule-Remote_1-day_FINAL.pdf
- Majocchi's granuloma—A multicenter retrospective cohort study - PMC
- Nonlinear optical microscopy is a novel tool for the analysis of cutaneous alterations in pseudoxanthoma elasticum - PMC
- Histology of hidradenitis suppurativa - Region Sjælland
- Clear vesicular eruption in the intensive care unit - PMC
- Erythema Nodosum: Clinicopathologic Correlations and Their Use in Differential Diagnosis - PMC
Confirm current eligibility, fees, scheduling and policies directly with the examination provider. CertMedbry is independent and is not endorsed by these organisations. How we handle content and corrections.